Post job

Pluristem Therapeutics overview

Industry
Biotechnology
Revenue
Employees
180
Founded in
Website
Organization type
Public
Social media
Pluristem Therapeutics is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases. Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem's pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product. The company's GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals.
Pluristem Therapeutics is a small health care company based in the United States with only 180 employees and an annual revenue of $234,000.

Pluristem Therapeutics's mission statement

To develop powerful cell therapies that can be successfully commercialized to reach patients who need innovative treatment options.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration
-

Pluristem Therapeutics employee reviews

Be the first to review!

Do you work at Pluristem Therapeutics?

Help job seekers learn about working at Pluristem Therapeutics

On this page

Be the first to review Pluristem Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Pluristem Therapeutics?

The team at Pluristem Therapeutics

  • The founders of Pluristem Therapeutics is Shai Meretzki.
  • The key people at Pluristem Therapeutics is Shai Meretzki.
Key people
Shai Meretzki

Rate the Pluristem Therapeutics' inclusivity.

Zippia waving zebra

Do you work at Pluristem Therapeutics?

Does Pluristem Therapeutics actively promote diversity and inclusion?

Pluristem Therapeutics financial performance

6.6
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Pluristem Therapeutics currently has 287.0K in revenue. Pluristem Therapeutics's most recent quarter produced 111.0k (q4'2023).

Pluristem Therapeutics annual revenue

$3M
$2M
$2M
$1M
$570,000
$0
2015
2016
2018
2019
2020
2022

Highest paying Pluristem Therapeutics competitors

Compare Pluristem Therapeutics salaries to competitors, including Iovance Biotherapeutics, Gilead Sciences, and Vertex Pharmaceuticals. Employees at Iovance Biotherapeutics earn the highest average yearly salary of $101,673. The salaries at Gilead Sciences average $99,828 per year, and the salaries at Vertex Pharmaceuticals come in at $95,952 per year.
RankCompanyAverage salaryJobs
1$101,6730
2$99,8280
3$95,9520
4$90,4600
5$90,3280
6$70,1570
7$59,6460
8$56,8510
9$50,6030
10$50,3660

Are you an executive, HR leader, or brand manager at Pluristem Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Pluristem Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Pluristem Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pluristem Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Pluristem Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pluristem Therapeutics. The data presented on this page does not represent the view of Pluristem Therapeutics and its employees or that of Zippia.

Pluristem Therapeutics may also be known as or be related to PLURISTEM THERAPEUTICS INC, Pluristem Therapeutics, Pluristem Therapeutics Inc, Pluristem Therapeutics Inc. and Pluristem Therapeutics, Inc.